Associate Director, Bio-Markers
Eikon Therapeutics - new york city, NY
Apply NowJob Description
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon's discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets. Position As the Associate Director, Bio-Markers, you will play a crucial role in driving the discovery and utilization of biomarkers for our groundbreaking biotechnology solutions. Collaborating closely with interdisciplinary teams, you will lead efforts to identify, validate, and interpret biomarkers, ultimately contributing to the development of novel diagnostic and therapeutic approaches. This role will require a minimum of 3 days a week of onsite presence (or more as business needs require) in either our New York or New Jersey office to ensure effective management, operational excellence and high-performance delivery of clinical studies and to support the expected significant team growth & collaboration. About You The ideal candidate should demonstrate expertise in biomarker discovery, validation, and interpretation, possess a strong background in molecular biology, genomics, or proteomics, and be proficient in data analysis tools and bioinformatics. Additionally, they should have excellent analytical and problem-solving skills, effective communication abilities, a passion for innovative research, and the ability to excel in a dynamic and interdisciplinary biotech environment. What You'll Do Collaborate with cross-functional teams to develop and execute strategies for the identification and application of biomarkers in alignment with company goals. Contribute to efforts to identify and evaluate potential biomarkers through data analysis, experimentation, and advanced technology utilization. Collaborate with cross-functional teams including clinical, research, and regulatory to develop and implement biomarker plans, contribute to clinical protocols, writing ICFs for clinical trials. Contribute to CDx strategy and to execute the implementation of companion diagnostics (CDx) in support of clinical studies. Oversee the validation of biomarker assays through rigorous scientific methods, ensuring accurate and reliable results for downstream applications. Analyze complex biological and clinical data sets, extracting meaningful insights to inform biomarker selection and interpretation of clinical data. Foster collaborations with internal and external partners to leverage diverse expertise and advance clinical biomarker research. Contribute to the dissemination of research findings through publications, presentations, and engagement with the clinical teams as well as the scientific community. Qualifications Post Graduate degree with 8+ years of relevant experience or a Bachelor' degree with 10+ years of relevant experience in a relevant field, such as Biology, Biochemistry, Biotechnology, or a related discipline. Demonstrated experience in biomarker discovery, validation, and interpretation within a research or biotech setting. Strong background in molecular biology, genomics, biochemistry, immunology, cell biology, or other relevant biological disciplines. Proficiency in data analysis tools, bioinformatics, and statistical methods for biomarker analysis. Excellent analytical and problem-solving skills, with the ability to interpret complex data and draw meaningful conclusions. Effective communication skills for collaboration with diverse teams and presentation of findings. Passion for innovative research and technology integration in the pursuit of advancing biotechnology. Ability to excel in a dynamic, fast-paced, and interdisciplinary biotech environment. Experience developing companion diagnostics a plus. Experience leading biomarker oncology studies a plus. At Eikon, employee compensation also includes bonus and equity compensation, in addition to several generous benefit programs, including: 401k plan with company matching Medical (premiums covered by Eikon at 95%), dental and vision insurance (premiums covered by Eikon at 100%) Mental health and wellness benefits Weeklong summer and winter holiday shutdowns Generous paid time off and holiday policies Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee-paid life/AD&D policies Enhanced parental leave benefit Daily subsidized lunch program when on-site The expected salary range for this role is $165,000 to $180,500 depending on skills, competency, and the market demand for your expertise. Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment. In accordance with the Company's duty to provide and maintain a safe workplace, the Company requires all employees to be Fully Vaccinated with one of the FDA approved COVID-19 vaccines, which includes those vaccines that have received the FDA's emergency use authorization. You will be expected to be Fully Vaccinated as of your Start Date. If you believe that you are exempt from this requirement under an applicable law or regulations, including Americans with Disabilities Act and California's Fair Employment and Housing Act, you will need to contact the Company's Human Resources group. For purposes of this section, Fully Vaccinated means (i) the completion of the vaccination regimen as approved by the FDA (by way of example, 2 doses of the Pfizer or Moderna vaccine and 1 dose of the Johnson and Johnson vaccine), and (ii) timely receiving booster vaccination, as recommended by the Centers for Disease Control and Prevention. We are currently not accepting any new third-party agencies or firms at this time. Please do not forward unsolicited agency resumes to our website, employees or Human Resources. Eikon Therapeutics will not pay fees to any third-party agency or firm associated with unsolicited resumes.
Created: 2024-10-19